Volume 27, Issue 5 (Iran South Med J 2025)
Iran South Med J 2025, 27(5): 384-393 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Alizadeh M, Rashidi Evandi M, Jafar Sameri M, Senisel Bachari E, Kogani M. Retention in HIV Care Programs and Its Association with Comorbidity Incidence and Viral Load Reduction. Iran South Med J 2025; 27 (5) :384-393
URL: http://ismj.bpums.ac.ir/article-1-2141-en.html
URL: http://ismj.bpums.ac.ir/article-1-2141-en.html
Majid Alizadeh1 
, Mohammad Rashidi Evandi2 , Maryam Jafar Sameri *3 , Elham Senisel Bachari2 , Mohammad Kogani4
, Mohammad Rashidi Evandi2 , Maryam Jafar Sameri *3 , Elham Senisel Bachari2 , Mohammad Kogani4
1- Medical Management and Information Department, School of Health Management and Information Sciences, Shi-raz University of Medical Sciences, Shiraz, Iran
2- Department of Medical Basic Sciences, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran
3- Department of Medical Basic Sciences, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran ,M.Jafarsameri@Abadanums.ac.ir
4- Department of Biostatistics and Epidemiology, School of Health, Research Center for Environmental Contaminants, Abadan University of Medical Sciences, Abadan, Iran
2- Department of Medical Basic Sciences, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran
3- Department of Medical Basic Sciences, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran ,
4- Department of Biostatistics and Epidemiology, School of Health, Research Center for Environmental Contaminants, Abadan University of Medical Sciences, Abadan, Iran
Abstract: (72 Views)
Background: The human immunodeficiency virus (HIV) remains a critical global public health challenge, contributing to a growing burden of comorbidities and diminished quality of life among affected individuals. This study aimed to examine the association between retention in HIV care programs and the occurrence of comorbidities, as well as its impact on viral load suppression.
Materials and Methods: This descriptive-analytical study included 190 HIV-positive patients (out of 202 active records) aged over 18 years who were monitored at the Khorramshahr Behavioral Diseases Counseling Center between 2017 and 2022. Demographic data, treatment characteristics, and clinical information were extracted from medical records. Data were analyzed using SPSS software, with statistical tests including ANOVA and Pearson’s correlation coefficient.
Results: The study found that 68.4% of the patients had high retention (attending>70% of scheduled visits), 26.3% had moderate retention (40–70%), and 5.3% had low retention (<40%). Higher retention was associated with increased CD4 counts and lower viral loads. Additionally, better socioeconomic status and higher education levels correlated with improved CD4 levels and reduced viral loads. Over half of the patients (55.3%) had at least one comorbidity, with hepatitis B, hepatitis C, and tuberculosis being the most prevalent.
Conclusion: Retention in HIV care programs is linked to enhanced immune function (higher CD4 counts) and improved viral suppression. These findings underscore the need for comprehensive support programs to promote treatment adherence, manage comorbidities, and enhance the quality of life for individuals with HIV.
Materials and Methods: This descriptive-analytical study included 190 HIV-positive patients (out of 202 active records) aged over 18 years who were monitored at the Khorramshahr Behavioral Diseases Counseling Center between 2017 and 2022. Demographic data, treatment characteristics, and clinical information were extracted from medical records. Data were analyzed using SPSS software, with statistical tests including ANOVA and Pearson’s correlation coefficient.
Results: The study found that 68.4% of the patients had high retention (attending>70% of scheduled visits), 26.3% had moderate retention (40–70%), and 5.3% had low retention (<40%). Higher retention was associated with increased CD4 counts and lower viral loads. Additionally, better socioeconomic status and higher education levels correlated with improved CD4 levels and reduced viral loads. Over half of the patients (55.3%) had at least one comorbidity, with hepatitis B, hepatitis C, and tuberculosis being the most prevalent.
Conclusion: Retention in HIV care programs is linked to enhanced immune function (higher CD4 counts) and improved viral suppression. These findings underscore the need for comprehensive support programs to promote treatment adherence, manage comorbidities, and enhance the quality of life for individuals with HIV.
Type of Study: Original |
Subject:
Hospitals and Other Health Facilities
Received: 2025/01/11 | Accepted: 2025/05/11 | Published: 2025/06/1
Received: 2025/01/11 | Accepted: 2025/05/11 | Published: 2025/06/1
References
1. Brundrett ME. Human Immunodeficiency Virus Preexposure Prophylaxis in Adolescents and Young Adults. Pediatr Rev 2022; 43(1): 28-36. [DOI]
2. Deminice R, Oliveira VHF, Webel AR, et al. Sarcopenia Related to Human Immunodeficiency Virus: Protective Effects of Exercise. Exerc Sport Sci Rev 2022; 50(2): 73-80. [DOI]
3. Karnan A, Jadhav U, Ghewade B, et al. HIV Versus the Human Body: A Case Report of an Immunity-Compromised Patient. Cureus 2024; 16(6): e62942. [DOI]
4. Kirkoyun Uysal H, Koksal MO, Sarsar K, et al. Distribution of Opportunistic Pathogens in People Living with HIV at a University Hospital in Istanbul over a One-Year Treatment Period and Its Association with CD4 T Cell Counts. Pathogens 2023; 12(10): 1226. [DOI]
5. Saeed A, Mohammed Z. Cultural and religious barriers in the Middle East leading to delayed management of acute HIV case resulting in irreversible blindness: a case report. Ann Med Surg (Lond) 2023; 85(6): 3070-4. [DOI]
6. WHO. POLICY BRIEF ON INTEGRATING AND STRENGTHENING MONITORING OF DIFFERENTIATED ART SERVICE DELIVERY. (Accessed December 18, 2023) [Article]
7. Chirouze C, Journot V, Le Moing V, et al. Viremia copyyears as a predictive marker of all-cause mortality in HIV-1-infected patients initiating a protease inhibitorcontaining antiretroviral treatment. J Acquir Immune Defic Syndr 2015; 68(2): 204-8. [DOI]
8. Kim HN, Nance R, Van Rompaey S, et al. Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis. J Acquir Immune Defic Syndr 2016; 72(4): 437-43. [DOI]
9. Lundgren JD, Babiker AG, Gordin F, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 2015; 373(9): 795-807. [DOI]
10. Myers JE, Xia Q, Torian LV, et al. Implementation and Operational Research: CD4 Count Monitoring Frequency and Risk of CD4 Count Dropping Below 200 Cells Per Cubic Millimeter Among Stable HIV-Infected Patients in New York City, 2007-2013. J Acquir Immune Defic Syndr 2016; 71(3): e73-8. [DOI]
11. Slim J, Saling CF. A Review of Management of Inflammation in the HIV Population. Biomed Res Int 2016; 3420638. [DOI]
12. Farahat FM, Alghamdi YS, Farahat AF, et al. The prevalence of comorbidities among adult people diagnosed with HIV infection in a tertiary care hospital in western Saudi Arabia. J Infect Public Health. 2020; 13(11): 1699-704. [DOI]
13. Hernández I, Barzallo J, Beltrán S, et al. Increased incidences of noninfectious comorbidities among aging populations living with human immunodeficiency virus in Ecuador: a multicenter retrospective analysis. HIV AIDS (Auckl) 2019; 11: 55-9. [DOI]
14. Heron JE, Bagnis CI, Gracey DM. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res Ther 2020; 17(1): 11. [DOI]
15. Patel V, Chatterji S. Integrating Mental Health In Care For Noncommunicable Diseases: An Imperative For Person-Centered Care. Health Aff (Millwood) 2015; 34(9): 1498-505. [DOI]
16. Haberer JE, Bwana BM, Orrell C, et al. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa .J Int AIDS Soc 2019; 22(2): e25232. [DOI]
17. Laher AE, Richards GA, Paruk F, et al. Antiretroviral therapy non-adherence among HIV-positive patients presenting to an emergency department in Johannesburg, South Africa: Associations and reasons. S Afr Med J 2021;111(8): 753-8. [Article]
18. Moitra E, Chan PA, Molina PE, et al. HIV Engage-A randomized controlled efficacy trial of an acceptancebased behavioral therapy intervention to improve retention in care for HIV treatment naïve patients: Study protocol. Contemp Clin Trials 2021; 108: 106514. [DOI]
19. Guaraldi G, Orlando G, Zona S, et al. Premature agerelated comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53(11): 1120-6. [DOI]
20. Alhaj M, Amberbir A, Singogo E, et al. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study. J Int AIDS Soc 2019; 22(2): e25239. [DOI]
21. Masuke R, Kihaga Y, Mashala M, et al. Twelve months antiretroviral therapy retention among clients newly enrolled to care and treatment services in Geita Regin, Tanzania: does universal test and treat matter?. Pan Afr Med J 2023; 46(1): 20. [Article]
22. Mugenyi L, Nanfuka M, Byawaka J, et al. Effect of universal test and treat on retention and mortality among people living with HIV-infection in Uganda: An interrupted time series analysis. PLoS One 2022; 17(5): e0268226. [DOI]
23. Batey DS, Kay ES, Westfall AO, et al. Are missed- and kept-visit measures capturing different aspects of retention in HIV primary care?. AIDS Care 2019; 32(1): 98-103. [DOI]
24. Brites C, Nogueira RS ,Gosuen GC, et al. Short Communication: Getting Older with HIV: Increasing Frequency of Comorbidities and Polypharmacy in Brazilian HIV Patients. AIDS Res Hum Retroviruses 2019; 35(11-12): 1103-5. [DOI]
25. Fischetti B, Sorbera M, Michael R, et al. Evaluation of rates of virologic suppression in HIV-positive patients with varying numbers of comorbidities. Am J Health Syst Pharm 2022; 79(2): 72-7. [DOI]
26. Garagiola E, Foglia E, Ferrario L, et al .Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practice. Health Econ Rev. 2020; 10(1): 27. [DOI]
27. Glynn TR, Safren SA, Carrico AW, et al. High Levels of Syndemics and Their Association with Adherence, Viral Non-suppression, and Biobehavioral Transmission Risk in Miami, a U.S. City with an HIV/AIDS Epidemic. AIDS Behav 2019; 23(11): 2956-65. [DOI]
28. Mane P, Aggleton P. Gender and HIV/AIDS: what do men have to do with it?. Current Sociology 2001; 49(6): 23-37. [DOI]
29. Kasavandi A, Foroohi F, Rahimi T, et al. Investigating the Prevalence of Mycobacterium Tuberculosis in Patientsinfected with HIV Microscopically and Molecularly. Armaghane Danesh 2023; 28(2): 260-74. [DOI]
30. Yaghoobi H, Ahmadiniya H, Shabani Z, et al. The Epidemiological Investigation of Patients with HIV/AIDS in Bandar Abbas Behavioral Disorders Counseling Center During 2005-2015. J Rafsanjan Univ Med Sci 2018; 16(10): 969-82. [Article]
31. Daryazadeh S, Maryami F. Epidemiological investigation of HIV-positive patients in Isfahan Behavioral Consultation Center, Iran. J Isfahan Med School 2013; 31(258): 1744-55. (persian) [Article]
32. Daryazadeh S, Kuhpayehzadeh J. Prevalence of simultaneous infections and causes of death of positiveHIV patients in incubation and AIDS phases. Razi J Med Sci 2016; 22(139): 46-55. (persian) [Article]
33. Kashi A, Yadyad M, Hajiabdolbaghi M, et al. Utilization of the Health Ministry recommended services by Iranian HIV/AIDS patients. Tehran Univ Med J 2008; 66(9): 670-676. (persian) [Article]
34. Audet CM, Clemens EM, Ngobeni S, et al. Throwing the bones to diagnose HIV: Views of rural South African traditional healers on undertaking HIV counselling and testing. AIDS Care 2021; 33(10): 1316-20. [DOI]
35. Chellaiyan VG, Raut DK, Khokhar A. Integrated counseling and HIV testing centers of Delhi: An evaluation . J Family Med Prim Care 2018; 7(4): 791-5. [DOI]
36. Aleebrahim F, Kamali K, Nasirian M. Status of Service Provision Centers for Patients with Sexually Transmitted infections in Tehran, Kerman, Babol and Shiraz as Representatives of Iran’s Capital Cities in 2013. Iran South Med J 2020; 23(3): 266-79. [Article]
37. May M, Gompels M, Delpech V, et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. Bmj 2011; 343. [DOI]
38. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PloS one 2013; 8(12): e81355. [DOI]
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
